Building the Australian response to the ‘superbugs’ crisis

制定澳大利亚应对“超级细菌”危机的措施

• 批准号: DP170100937
• 负责人: A/Prof Mark Davis
• 金额: $ 27.43万
• 依托单位: Monash University
• 依托单位国家: 澳大利亚
• 项目类别: Discovery Projects
• 财政年份: 2017
• 资助国家: 澳大利亚
• 起止时间: 2017-06-30 至 2021-06-30
• 项目状态: 已结题
• 来源: https://dataportal.arc.gov.au/RGS/Web/Grants/DP170100937
• 关键词: Building; Australian; response; superbugs; crisis

This project aims to investigate the Australian public’s engagement with communications and media on antimicrobial resistance, examine the public’s trust in expert knowledge and study how the public enacts expert advice about antimicrobial drugs in everyday life. The resistance of common infections to antibiotics and other drugs (the ‘superbugs’ crisis) jeopardises health worldwide. The ‘superbugs’ crisis means that individuals and care givers need to use drugs as prescribed and reduce their expectations for drug treatments. Research findings are expected to underpin Australia’s public health policy and communications response to ‘superbugs’, improving national and international health outcomes.

该项目旨在调查澳大利亚公众与抗菌素抵抗的传播和媒体的参与，研究公众对专家知识的信任，并研究公众在日常生活中如何颁布有关抗菌药物的专家建议。常见感染对抗生素和其他药物（“超级细菌”危机）的抗性危害了全世界的健康。 “超级分布”危机意味着个人和护理人员需要使用规定的药物并减少对药物治疗的期望。预计研究结果将支持澳大利亚对“超级细菌”的公共卫生政策和沟通反应，从而改善国家和国际健康成果。